Viewing Study NCT07235059

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 2:44 PM
Ignite Modification Date: 2026-02-08 @ 2:09 PM
Study NCT ID: NCT07235059
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2025-11-14
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney Disease
Sponsor: Novartis Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Kidney Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None OJR520 View
None safety and tolerability View
None PK View
None PD View
None healthy volunteers View
None first in human View
None chronic kidney disease View